|
SEC Associates, Inc., is proudly celebrating 20 years of service. For most of that time, SEC was a recognized leader in regulatory compliance consulting and computer validation services to Life Sciences clients around the globe.
Beginning in late 2005, SEC started down a new path. In that year, SEC was retained by Eli Lilly and Company to conduct a third-party audit of Lilly’s Clinical Trial Registry and Results Disclosure databases. It was during the course of this audit, as well as subsequent clinical trial transparency assessments and consulting engagements with other clients, that SEC began to recognize a growing need for highly specialized consulting in this niche field.
In 2007 SEC was engaged by a leading biotech company to conduct research and produce a detailed report on Clinical Trial Registration and Results Disclosure laws, regulations, guidelines, and expectations for 26 non-U.S. countries. Recognizing the importance of this information to the Life Sciences industry at large, SEC retained the rights to license the original 18 December 2008 report to other clients, and to grow the report with additional countries, expanded information, and increased usability.
SEC recognized that the ultimate benefit of this rich source of information could only be realized by building a web-based repository that would enable users to get the information they need quickly and easily, using only a browser. Developing and deploying this web application is the primary focus of SEC Associates today. The result is TransparentCT™ - The International Clinical Trial Disclosure Knowledge Base.
While working on the development of TransparentCT™ online, SEC issued an updated edition of the original PDF report on 18 April 2008. This edition included 6 new entries for a total of 32 non-U.S. countries, and included updated information for many of the existing countries. TransparentCT.com is slated for general availability on a subscription basis in late summer of 2008. It will be continually expanded and updated with new information and additional countries (including the U.S.), as well as features and functions only available from the power of a relational database.
The true value of TransparentCT™, however, lies not only in its underlying technology, but also in the rich repository of current, hard-to-find information on clinical trial transparency requirements from around the world. The savings in research, analysis, and reporting time that can be realized by using TransparentCT™ can free up much needed resources for your organization. This, today, is what SEC Associates is all about.
|
Overview